Gadodiamide (hydrate)

98.10%

Gadodiamide (hydrate)

质检下载产品说明书产品使用指南

品牌：源叶(MedMol)

产品编号：S81249 一键复制产品信息

CAS号：122795-43-1

分子式：C₁₆H₂₈GdN₅O₉

分子量：591.6716

别名：钆双胺一水合物;Gadodiamide hydrate; Omniscan; 2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetate,gadolinium(3+),hydrate;

货号	规格	价格	上海	北京	珠海	重庆	武汉
S81249-50mg	98.10%	￥300.00 S81249-50mg ￥300.00 现货	5 5	-	-	-	-
S81249-250mg	≥98%	￥390.00 S81249-250mg ￥390.00 2-3天	0 货期：2-3天	-	-	-	-
S81249-1g	≥98%	￥940.00 S81249-1g ￥940.00 2-3天	0 货期：2-3天	-	-	-	-

大包装询价收藏产品

加入购物车

产品介绍参考文献质检证书(COA) 摩尔浓度计算器相关产品

产品描述：

Gadodiamide hydrate is a gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. Target: Others Gadodiamide hydrate is a gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. Gadodiamide hydrate is a contrast medium for cranial and spinal magnetic resonance imaging (MRI) and for general MRI of the body after intravenous administration. The product provides contrast enhancement and facilitates visualisation of abnormal structures or lesions in various parts of the body including the central nervous system (CNS). A recent review takes the question of toxicity caused by loss of gadolinium from the complex. 'The challenge for nephrologists includes (a) evidence of transmetallation, such as gadolinium deposits in bone, increased urinary zinc excretion, iron-transferrin dissociation or 'spurious hypocalcemia' in exposed people'

靶点：

Biochemical Assay Reagents;Others

参考文献：

1. Canavese, C., et al., Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness. J Nephrol, 2008. 21(3): p. 324-36.

溶解性：

Soluble in DMSO、H2O

保存条件：

-20℃

配置溶液浓度参考：